Image

Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)

Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found.

The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.

Description

The protocol, which is done during the usual follow-up consultation of the patient by the maxillo-facial surgeon, is divided into 3 parts:

PART 1: Collection of Data and Consent

  • Patient Data:
  • Date of visit and inclusion in the study
  • Patient initials
  • Age
  • Gender (male or female)
  • The weight
  • The size
  • Verification of inclusion and non-inclusion criteria:
  • General patient history:
  • Patient history
  • Ongoing Treatments
  • Professional activity
  • Tumor:
  • Features
  • Location
  • TNM
  • Histological type
  • Search for risk factors for peripheral neuropathy
  • Check for symptoms of peripheral neuropathy.

PART 2: Collecting Treatment Data

  • Operating data:
  • Operation date
  • Type of surgery
  • Duration of surgery
  • Severed sensory nerves
  • Perioperative complications
  • On the way out:
  • Adjuvant treatment including radiotherapy and/or chemotherapy.
  • Exit analgesic treatment
  • EN (Numerical Scale)

PART 3: Collection of data related to neurosensory disorders and pain

  • Analgesics consumed
  • Questionnaire DN4 for each operated area separated according to the curage, lumpectomy and reconstruction if they take place.
  • If DN4 positive, completion of the QCD and QEDN questionnaires.
  • Clinical examination for sensory disturbances reported on a chart.
  • Generic quality of life questionnaire adapted to cancer pathology EORTC QLQC30 and its specific Head and Neck35 add-on module adapted to head and neck cancers.
  • Thermotest and hot water, cold water (for the oral cavity)
  • HADS Questionnaire
  • Catastrophe Questionnaire
  • Quantitative sensory testing (QST) for neuropathic patients :

Mechanical neurosensory disorders will be tested with the Von frey filament and the brush.

  • Hypoesthesia or mechanical anaesthesia will be sought with the Von Frey filament and the brush.
  • Mechanical hypersensitivity, a painful sensation exacerbated by a sharp, non-traumatic object, will be sought with a large calibre Von Frey filament.
  • Static Allodynia, felt painful on contact, will be sought at Von Frey's filament.
  • Dynamic Allodynia, felt painful when rubbed, will be sought with a wide brush (8 mm) over a distance of several centimetres.

Thermal neurosensory disorders will be sought for the skin with the Thermotest and at the level of the oral cavity with the application of standardised test tubes containing water at 4°C stored in the fridge or hot water at 63°C (the protocol consists of heating water at 4°C in the microwave for 30 seconds to obtain the temperature of 63°C); these examinations will allow the evaluation of thermal allodynia and hypoesthesia.

The examination will cover the entire face, the oral cavity, the cervical region and the area where the reconstruction flaps are taken. The pathological areas identified will be delimited on diagrams previously made with a coding according to the sensations collected.

Eligibility

Inclusion Criteria:

  • Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years.
  • Women or men upper 18 years old)
  • Patient with full consent, aware and signed
  • Patient cover by the French social security system

Exclusion Criteria:

  • Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol
  • Pregnant women or nursing
  • Patients who can't comply with the protocol
  • Participation refusal
  • Inable full age patient or under judicial protection

Study details
    Head Cancer
    Neck Cancer
    Chronic Pain

NCT04673981

University Hospital, Clermont-Ferrand

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.